STRO - Sutro Biopharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STRO is currently covered by 6 analysts with an average price target of $15.45. This is a potential upside of $5.64 (57.49%) from yesterday's end of day stock price of $9.81.

Sutro Biopharma's activity chart (see below) currently has 78 price targets and 64 ratings on display. The stock rating distribution of STRO is 25% BUY, 50% HOLD and 25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.16% with an average time for these price targets to be met of 170.9 days.

Highest price target for STRO is $3, Lowest price target is $0.8, average price target is $1.96.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 12-Aug-2025. First documented stock forecast 22-Oct-2018.

Currently out of the existing stock ratings of STRO, 2 are a BUY (25%), 4 are a HOLD (50%), 2 are a SELL (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$3

$1.88 (167.86%)

$5

4 months ago
(12-Aug-2025)

1/2 (50%)

$2.22 (284.62%)

99

Buy

$2

$0.88 (78.57%)

$11

5 months 26 days ago
(16-Jun-2025)

4/11 (36.36%)

$1.12 (127.27%)

402

Sell

$0.8

$-0.32 (-28.57%)

$1

6 months 23 days ago
(19-May-2025)

2/3 (66.67%)

$-0.08 (-9.09%)

33

Hold

$2

$0.88 (78.57%)

$12

8 months 25 days ago
(17-Mar-2025)

0/12 (0%)

$1.07 (115.05%)

Hold

$2

$0.88 (78.57%)

$8

8 months 28 days ago
(14-Mar-2025)

2/10 (20%)

$1.19 (146.91%)

708

Show more analysts

Please expand the browser size to see the chart

What is STRO (Sutro Biopharma) average time for price targets to be met?

On average it took 170.9 days on average for the stock forecasts to be realized with a an average price target met ratio 26.16

Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?

KONSTANTINOS APRILAKIS

Which analyst has the most public recommendations on STRO (Sutro Biopharma)?

Konstantinos Aprilakis has 5 price targets and 3 ratings on STRO

Which analyst is the currently most bullish on STRO (Sutro Biopharma)?

Konstantinos Aprilakis with highest potential upside - $33.88

Which analyst is the currently most reserved on STRO (Sutro Biopharma)?

Tazeen Ahmad with lowest potential downside - -$0.32

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?